This invention relates to novel aminoglycoside antibiotics, which have potent antimicrobial activity against bacteria, which induce infectious diseases, particularly MRSA, and has no significant nephrotoxicity, and process for producing them. More particularly, the present invention relates to compounds represented by formula (Ia) or their pharmacologically acceptable salts or solvates, or their diastereomer mixtures, antimicrobial agents comprising them, and a process for producing them.
本发明涉及一种新型
氨基糖苷类抗生素,对引起传染病的细菌,特别是MRSA具有强效的抗微
生物活性,并且没有显著的肾毒性,并提供了其生产方法。更具体地说,本发明涉及由式(Ia)表示的化合物或其药理学上可接受的盐或溶剂或其对映体混合物,包含它们的抗微
生物剂以及生产它们的方法。